AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Pharmacotherapy

Results: 1-25/876
AMIODARONE - THE REEMERGENCE OF A UNIQUE ANTIARRHYTHMIC DRUG - INTRODUCTION
Authors: BAUMAN JL
Citation: Jl. Bauman, AMIODARONE - THE REEMERGENCE OF A UNIQUE ANTIARRHYTHMIC DRUG - INTRODUCTION, Pharmacotherapy, 18(6), 1998, pp. 119-120
ORAL AMIODARONE - HISTORICAL OVERVIEW AND DEVELOPMENT
Authors: POLLAK PT
Citation: Pt. Pollak, ORAL AMIODARONE - HISTORICAL OVERVIEW AND DEVELOPMENT, Pharmacotherapy, 18(6), 1998, pp. 121-126
CLINICAL EFFICACY OF AMIODARONE
Authors: NOLAN PE NAPPI J POLLAK PT
Citation: Pe. Nolan et al., CLINICAL EFFICACY OF AMIODARONE, Pharmacotherapy, 18(6), 1998, pp. 127-137
OPTIMAL MANAGEMENT OF AMIODARONE THERAPY - EFFICACY AND SIDE-EFFECTS
Authors: HILLEMAN D MILLER MA PARKER R DOERING P PIEPER JA
Citation: D. Hilleman et al., OPTIMAL MANAGEMENT OF AMIODARONE THERAPY - EFFICACY AND SIDE-EFFECTS, Pharmacotherapy, 18(6), 1998, pp. 138-145
RATIONALE, DEVELOPMENT, AND CLINICAL OUTCOMES OF A MULTIDISCIPLINARY AMIODARONE CLINIC
Authors: SANOSKI CA SCHOEN MD GONZALEZ RC AVITALL B BAUMAN JL
Citation: Ca. Sanoski et al., RATIONALE, DEVELOPMENT, AND CLINICAL OUTCOMES OF A MULTIDISCIPLINARY AMIODARONE CLINIC, Pharmacotherapy, 18(6), 1998, pp. 146-151
AMIODARONE - THE REEMERGENCE OF A UNIQUE ANTIARRHYTHMIC DRUG
Citation: AMIODARONE - THE REEMERGENCE OF A UNIQUE ANTIARRHYTHMIC DRUG, Pharmacotherapy, 18(6), 1998, pp. 152-156
QUETIAPINE, AN ATYPICAL ANTIPSYCHOTIC
Authors: GOREN JL LEVIN GM
Citation: Jl. Goren et Gm. Levin, QUETIAPINE, AN ATYPICAL ANTIPSYCHOTIC, Pharmacotherapy, 18(6), 1998, pp. 1183-1194
REPAGLINIDE, A NOVEL, SHORT-ACTING HYPOGLYCEMIC AGENT FOR TYPE-2 DIABETES-MELLITUS
Authors: GUAY DRP
Citation: Drp. Guay, REPAGLINIDE, A NOVEL, SHORT-ACTING HYPOGLYCEMIC AGENT FOR TYPE-2 DIABETES-MELLITUS, Pharmacotherapy, 18(6), 1998, pp. 1195-1204
PHARMACOKINETICS OF PYRAZINAMIDE UNDER FASTING CONDITIONS, WITH FOOD,AND WITH ANTACIDS
Authors: PELOQUIN CA BULPITT AE JARESKO GS JELLIFFE RW JAMES GT NIX DE
Citation: Ca. Peloquin et al., PHARMACOKINETICS OF PYRAZINAMIDE UNDER FASTING CONDITIONS, WITH FOOD,AND WITH ANTACIDS, Pharmacotherapy, 18(6), 1998, pp. 1205-1211
ALTERATION IN INDINAVIR CLEARANCE DURING INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: PISCITELLI SC VOGEL S FIGG WD RAJE S FORREST A METCALF JA BASELER M FALLOON J
Citation: Sc. Piscitelli et al., ALTERATION IN INDINAVIR CLEARANCE DURING INTERLEUKIN-2 INFUSIONS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, Pharmacotherapy, 18(6), 1998, pp. 1212-1216
IN UNFRACTIONATED HEPARIN DOSING, THE COMBINATION OF PATIENT AGE AND ESTIMATED PLASMA-VOLUME PREDICTS INITIAL ANTI-FACTOR XA ACTIVITY BETTER THAN PATIENT WEIGHT ALONE
Authors: ROSBOROUGH TK
Citation: Tk. Rosborough, IN UNFRACTIONATED HEPARIN DOSING, THE COMBINATION OF PATIENT AGE AND ESTIMATED PLASMA-VOLUME PREDICTS INITIAL ANTI-FACTOR XA ACTIVITY BETTER THAN PATIENT WEIGHT ALONE, Pharmacotherapy, 18(6), 1998, pp. 1217-1223
THE PHARMACOKINETICS AND PHARMACODYNAMICS OF FLUDARABINE IN RHEUMATOID-ARTHRITIS
Authors: KNEBEL W DAVIS JC SANDERS WD FESSLER B YARBORO C PUCINO F BOUMPAS DT
Citation: W. Knebel et al., THE PHARMACOKINETICS AND PHARMACODYNAMICS OF FLUDARABINE IN RHEUMATOID-ARTHRITIS, Pharmacotherapy, 18(6), 1998, pp. 1224-1229
PHARMACOKINETICS OF DEXAMETHASONE AND VALSPODAR, A P-GLYCOPROTEIN (MDR1) MODULATOR - IMPLICATIONS FOR COADMINISTRATION
Authors: KOVARIK JM PURBA HS PONGOWSKI M GERBEAU C HUMBERT H MUELLER EA
Citation: Jm. Kovarik et al., PHARMACOKINETICS OF DEXAMETHASONE AND VALSPODAR, A P-GLYCOPROTEIN (MDR1) MODULATOR - IMPLICATIONS FOR COADMINISTRATION, Pharmacotherapy, 18(6), 1998, pp. 1230-1236
LACK OF EFFECT OF OLANZAPINE ON THE PHARMACOKINETICS OF A SINGLE AMINOPHYLLINE DOSE IN HEALTHY-MEN
Authors: MACIAS WL BERGSTROM RF CERIMELE BJ KASSAHUN K TATUM DE CALLAGHAN JT
Citation: Wl. Macias et al., LACK OF EFFECT OF OLANZAPINE ON THE PHARMACOKINETICS OF A SINGLE AMINOPHYLLINE DOSE IN HEALTHY-MEN, Pharmacotherapy, 18(6), 1998, pp. 1237-1248
ACUTE EFFECTS OF PRECHEMOTHERAPY FILGRASTIM ADMINISTRATION ON LATE HEMATOPOIETIC PROGENITOR CELLS
Authors: HIGA GM
Citation: Gm. Higa, ACUTE EFFECTS OF PRECHEMOTHERAPY FILGRASTIM ADMINISTRATION ON LATE HEMATOPOIETIC PROGENITOR CELLS, Pharmacotherapy, 18(6), 1998, pp. 1249-1254
A MULTICENTER, INVESTIGATOR-BLINDED, RANDOMIZED COMPARISON OF ORAL LEVOFLOXACIN AND ORAL CLARITHROMYCIN IN THE TREATMENT OF ACUTE BACTERIALSINUSITIS
Authors: ADELGLASS J JONES TM RUOFF G KAHN JB WIESINGER BA RIELLYGAUVIN K SIU CO
Citation: J. Adelglass et al., A MULTICENTER, INVESTIGATOR-BLINDED, RANDOMIZED COMPARISON OF ORAL LEVOFLOXACIN AND ORAL CLARITHROMYCIN IN THE TREATMENT OF ACUTE BACTERIALSINUSITIS, Pharmacotherapy, 18(6), 1998, pp. 1255-1263
RETROSPECTIVE AND PROSPECTIVE ANALYSES OF THE TREATMENT OF OVERANTICOAGULATED PATIENTS
Authors: DUONG TM PLOWMAN BK MORREALE AP JANETZKY K
Citation: Tm. Duong et al., RETROSPECTIVE AND PROSPECTIVE ANALYSES OF THE TREATMENT OF OVERANTICOAGULATED PATIENTS, Pharmacotherapy, 18(6), 1998, pp. 1264-1270
CYTOCHROME-P450 3A4 ACTIVITY IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN, BASED ON 6-BETA-HYDROXYCORTISOL CORTISOL RATIOS/
Authors: BURSTEIN AH REISS WG KANTOR E ANDERSON GD
Citation: Ah. Burstein et al., CYTOCHROME-P450 3A4 ACTIVITY IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN, BASED ON 6-BETA-HYDROXYCORTISOL CORTISOL RATIOS/, Pharmacotherapy, 18(6), 1998, pp. 1271-1276
ANTIEPILEPTICS AND BLOOD DYSCRASIAS - A COHORT STUDY
Authors: BLACKBURN SCF OLIART AD RODRIGUEZ LAG GUTTHANN SP
Citation: Scf. Blackburn et al., ANTIEPILEPTICS AND BLOOD DYSCRASIAS - A COHORT STUDY, Pharmacotherapy, 18(6), 1998, pp. 1277-1283
CHARACTERISTICS ASSOCIATED WITH ABILITY TO PREVENT ADVERSE DRUG-REACTIONS IN HOSPITALIZED-PATIENTS
Authors: SEEGER JD KONG SXD SCHUMOCK GT
Citation: Jd. Seeger et al., CHARACTERISTICS ASSOCIATED WITH ABILITY TO PREVENT ADVERSE DRUG-REACTIONS IN HOSPITALIZED-PATIENTS, Pharmacotherapy, 18(6), 1998, pp. 1284-1289
SAFETY OF GM-CSF IN PATIENTS WITH AIDS - A REVIEW OF THE LITERATURE
Authors: ROSS SD DIGEORGE A CONNELLY JE WHITING GW MCDONNELL N
Citation: Sd. Ross et al., SAFETY OF GM-CSF IN PATIENTS WITH AIDS - A REVIEW OF THE LITERATURE, Pharmacotherapy, 18(6), 1998, pp. 1290-1297
CONCOMITANT THERAPY WITH ANXIOLYTICS OR HYPNOTICS AND MAINTENANCE OF INITIAL SSRI THERAPY
Authors: SHIELDS SA GREGOR KJ YOUNG CH JAMES SP
Citation: Sa. Shields et al., CONCOMITANT THERAPY WITH ANXIOLYTICS OR HYPNOTICS AND MAINTENANCE OF INITIAL SSRI THERAPY, Pharmacotherapy, 18(6), 1998, pp. 1298-1303
PHARMACOKINETIC DRUG-INTERACTIONS OF VINCA ALKALOIDS - SUMMARY OF CASE-REPORTS
Authors: CHAN JD
Citation: Jd. Chan, PHARMACOKINETIC DRUG-INTERACTIONS OF VINCA ALKALOIDS - SUMMARY OF CASE-REPORTS, Pharmacotherapy, 18(6), 1998, pp. 1304-1307
WITHDRAWAL AFTER NARCOTIC THERAPY - A SURVEY OF NEONATAL AND PEDIATRIC CLINICIAN
Authors: SCOTT CS DECKER JL EDWARDS ML FREID EB
Citation: Cs. Scott et al., WITHDRAWAL AFTER NARCOTIC THERAPY - A SURVEY OF NEONATAL AND PEDIATRIC CLINICIAN, Pharmacotherapy, 18(6), 1998, pp. 1308-1312
SAFETY ISSUES IN THE PHARMACOLOGICAL MANAGEMENT OF CHRONIC PAIN IN THE ELDERLY
Authors: SHIMP LA
Citation: La. Shimp, SAFETY ISSUES IN THE PHARMACOLOGICAL MANAGEMENT OF CHRONIC PAIN IN THE ELDERLY, Pharmacotherapy, 18(6), 1998, pp. 1313-1322
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>